This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Delayed milestone in childhood
R18_DELAY_MILES_CHILDH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
680 |
4. Check minimum number of eventsNone |
680 |
5. Include endpointsNone |
680 |
6. Filter based on genotype QC (FinnGen only) |
680 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- R62
Similar endpoints
↥List of similar endpoints to
Delayed milestone in childhood
based on the number of shared cases.
Similar with more cases:
- Lack of expected normal physiological development
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 680 | 297 | 383 |
| Unadjusted period prevalence (%) | 0.14 | 0.10 | 0.17 |
| Median age at first event (years) | 2.82 | 2.50 | 3.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 605
- Matched controls
- 5492
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R62.0
ICD-10 Finland
Delayed milestone
+∞
323.0
606
40
F83
ICD-10 Finland
Mixed specific developmental disorders
14.8
101.1
184
157
XA800
NOMESCO Finland
Neuropsychological investigation
7.8
72.0
189
300
F82
ICD-10 Finland
Specific developmental disorder of motor function
11.8
60.9
120
112
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
5.4
59.2
216
511
R4110
NOMESCO Finland
Physiotherapy
4.4
56.4
280
904
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.5
51.5
150
263
RL140
NOMESCO Finland
NA
18.2
50.2
81
46
R4120
NOMESCO Finland
Occupational therapy
7.7
48.6
123
175
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.0
45.7
234
743
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.8
43.3
120
193
F80.1
ICD-10 Finland
Expressive language disorder
8.5
43.1
101
126
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
12.9
41.6
77
61
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.9
39.6
107
165
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
8.6
35.7
82
98
RT150
NOMESCO Finland
NA
10.6
34.4
70
67
RL130
NOMESCO Finland
NA
11.5
32.9
64
56
Z31.5
ICD-10 Finland
Genetic counselling
5.1
32.2
113
238
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
31.6
248
1028
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
13.9
31.1
55
39
F80.2
ICD-10 Finland
Receptive language disorder
8.3
30.6
71
86
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
27.9
191
709
Z50.5
ICD-10 Finland
Speech therapy
4.4
27.8
110
261
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.8
27.0
98
212
R4130
NOMESCO Finland
Speech therapy
6.4
27.0
75
118
N03AG01
ATC
valproic acid; systemic, rectal
5.1
24.4
82
163
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
23.7
116
331
602
Kela drug reimbursment
Children's severe malnutrition
5.0
23.4
80
162
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
22.8
140
473
RT490
NOMESCO Finland
NA
13.9
22.3
39
27
R1260
NOMESCO Finland
Evaluation of communicative skills
8.5
21.8
49
56
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
21.1
184
776
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.0
21.1
90
227
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.0
20.2
87
221
RS222
NOMESCO Finland
NA
7.3
19.4
48
64
H50.31
ICD-10 Finland
Intermittent exotropia
6.5
19.4
52
78
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.2
19.3
115
377
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.2
19.2
62
117
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
4.1
19.2
79
192
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
18.6
209
998
P85
ICPC
Mental retardation
8.6
18.5
41
46
FM2CE
NOMESCO Finland
NA
3.2
18.5
110
359
RT160
NOMESCO Finland
NA
7.8
18.3
43
53
N03AX14
ATC
levetiracetam; systemic
5.2
18.2
59
112
N05BA09
ATC
clobazam; oral
6.5
17.9
48
72
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
17.5
97
301
RT190
NOMESCO Finland
NA
15.3
17.4
29
18
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
17.4
242
1271
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
17.4
175
785
N05CD08
ATC
midazolam; nasal, systemic
4.7
17.4
62
131
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
17.2
143
577
RD210
NOMESCO Finland
NA
3.4
17.1
90
269
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
7.1
16.8
42
57
H01AC01
ATC
somatropin; parenteral
4.6
16.8
61
131
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.4
16.8
52
94
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
16.7
133
523
H50.30
ICD-10 Finland
Intermittent esotropy
6.5
16.6
44
65
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
17.5
16.5
26
14
DFF20
NOMESCO Finland
Audiometry for children
4.5
15.8
58
126
183
Kela drug reimbursment
Lamotrigin and topiramate
7.3
15.6
38
50
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
19.6
15.2
23
11
TJD20
NOMESCO Finland
Change of gastrostomy tube
8.1
15.0
34
40
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.6
14.9
71
196
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.0
14.2
86
283
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
29.6
14.2
19
6
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
19.7
14.0
21
10
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
13.9
97
350
WX882
NOMESCO Finland
High dependency care
2.5
13.8
121
496
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.7
13.8
48
99
N03AX09
ATC
lamotrigine; oral
4.4
13.8
51
112
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
15.9
13.6
22
13
A28
ICPC
Limited function/disability NOS
3.2
13.2
73
225
H50.0
ICD-10 Finland
Convergent concomitant strabismus
5.7
13.1
38
64
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
13.0
96
358
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
9.1
12.9
27
28
RS220
NOMESCO Finland
NA
4.9
12.9
43
85
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.9
12.7
83
285
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.1
12.6
50
118
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
12.5
127
562
H52.2
ICD-10 Finland
Astigmatism
3.9
12.5
53
133
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.2
12.2
27
31
N05AX08
ATC
risperidone; systemic
3.5
11.9
57
158
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
22.6
11.9
17
7
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.1
11.7
67
212
RT130
NOMESCO Finland
NA
14.8
11.5
19
12
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
11.5
86
321
H52.0
ICD-10 Finland
Hypermetropia
3.4
11.5
56
158
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
6.7
11.5
29
41
DFF00
NOMESCO Finland
Pure tone audiometry
3.3
11.4
59
174
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
11.2
247
1483
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
6.2
11.2
30
46
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
11.1
107
458
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.0
11.0
30
47
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
10.9
117
528
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
10.9
167
878
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
5.4
10.8
32
56
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
10.7
90
358
C03DA01
ATC
spironolactone; oral
4.2
10.6
40
90
E34.35
ICD-10 Finland
Abnormal growth retardation
3.4
10.6
52
147
WX722
NOMESCO Finland
PEEP
3.7
10.6
47
123
RS140
NOMESCO Finland
NA
8.9
10.6
22
23
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
6.8
10.5
26
36
R62.9
ICD-10 Finland
Lack of expected normal physiological development, unspecified
12.9
10.4
18
13
RS314
NOMESCO Finland
NA
12.9
10.4
18
13
XKD00
NOMESCO Finland
Uroflowmetry
3.5
10.4
49
135
H50.1
ICD-10 Finland
Divergent concomitant strabismus
8.0
10.3
23
27
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
8.6
10.3
22
24
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
25.9
10.2
14
5
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.1
10.2
57
176
XX4AW
NOMESCO Finland
NA
3.5
10.1
47
128
RF120
NOMESCO Finland
NA
8.9
10.1
21
22
P94.2
ICD-10 Finland
Congenital hypotonia
30.0
9.9
13
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
9.8
51
151
Q93.8
ICD-10 Finland
Other deletions from the autosomes
17.4
9.7
15
8
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.8
9.6
40
99
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.5
9.6
45
123
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
9.4
88
372
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
9.4
61
208
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
4.6
9.4
32
66
N05BA01
ATC
diazepam; systemic, rectal
3.1
9.3
52
161
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
9.8
9.2
18
17
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.5
9.2
43
118
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
4.2
9.2
34
76
G40.89
ICD-10 Finland
Other epilepsy
8.1
9.2
20
23
205
Kela drug reimbursment
Chronic hypertension
4.3
9.1
33
72
ZX114
NOMESCO Finland
Intramuscular
4.4
9.1
32
68
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
13.9
9.0
15
10
181
Kela drug reimbursment
Retigabine and vigabatrin
8.4
8.9
19
21
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.4
8.8
31
66
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
5.3
8.8
26
46
N03AX11
ATC
topiramate; oral
4.7
8.8
29
58
ZX199
NOMESCO Finland
Other rote
4.9
8.8
28
54
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
4.4
8.7
31
67
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.3
8.7
43
124
XF404
NOMESCO Finland
Ambulatory ECG
2.9
8.6
53
175
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.8
8.6
28
55
K03.66
ICD-10 Finland
Tooth plaque
2.0
8.6
120
604
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
8.5
132
690
M41.4
ICD-10 Finland
Neuromuscular scoliosis
10.6
8.5
16
14
RS211
NOMESCO Finland
NA
4.5
8.5
29
60
WX730
NOMESCO Finland
Conventional respirator
5.3
8.5
25
44
B01AA03
ATC
warfarin; systemic
4.9
8.5
27
52
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.5
133
699
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.8
8.5
53
179
WX002
NOMESCO Finland
Sedation and analgesia
2.4
8.3
73
296
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
7.4
8.3
19
24
N03AG04
ATC
vigabatrin; oral
7.4
8.3
19
24
N03AF02
ATC
oxcarbazepine; oral
3.2
8.2
43
129
RT274
NOMESCO Finland
NA
8.8
8.2
17
18
R62
ICD-10 Finland
Lack of expected normal physiological development
82.7
8.1
9
*
RS142
NOMESCO Finland
NA
10.7
8.1
15
13
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
8.1
42
126
RF420
NOMESCO Finland
NA
11.8
7.9
14
11
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
6.8
7.9
19
26
P07.3
ICD-10 Finland
Other preterm infants
2.8
7.9
51
177
C03CA01
ATC
furosemide; systemic
3.4
7.8
37
103
ZXA10
NOMESCO Finland
Bilateral
1.9
7.8
118
609
P07.2
ICD-10 Finland
Extreme immaturity
7.9
7.8
17
20
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
8.7
7.8
16
17
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
13.3
7.8
13
9
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
7.7
55
200
Q21.10
ICD-10 Finland
Persistent ostium secundum
3.2
7.7
40
120
301
Kela drug reimbursment
Growth hormone
4.5
7.7
26
54
J96.1
ICD-10 Finland
Chronic respiratory failure
15.8
7.7
12
7
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.0
7.6
44
141
R1250
NOMESCO Finland
Evaluation of functional capability
4.7
7.6
25
50
H47.2
ICD-10 Finland
Optic atrophy
10.8
7.6
14
12
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.1
7.5
28
64
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
7.5
105
528
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.2
7.4
27
60
Q75.3
ICD-10 Finland
Macrocephaly
12.0
7.4
13
10
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
7.4
37
108
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
41.3
7.4
9
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.6
7.4
53
193
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.7
7.3
48
168
R5599
NOMESCO Finland
Other rehabilitation service
3.2
7.3
37
109
F79
ICD-10 Finland
Unspecified mental retardation
13.8
7.3
12
8
WX402
NOMESCO Finland
General anaesthesia
1.8
7.3
147
836
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.6
7.3
31
80
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
23.0
7.2
10
*
N03AF03
ATC
rufinamide; oral
16.9
7.2
11
6
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.8
7.2
23
45
SPAT1229
SPAT
Assessment of need for aid
5.0
7.2
22
41
ZX108
NOMESCO Finland
Inhalation
4.5
7.1
24
50
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.4
7.0
33
92
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
3.3
7.0
34
97
WX892
NOMESCO Finland
Monitored bed care
2.2
7.0
68
293
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.7
7.0
45
156
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
5.0
6.9
21
39
UDC00
NOMESCO Finland
Ear microscopy
2.3
6.9
66
280
NF1DA
NOMESCO Finland
X-ray of hips
6.0
6.9
18
28
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
10.0
6.9
13
12
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
14.5
6.8
11
7
F88
ICD-10 Finland
Other disorders of psychological development
4.0
6.8
26
61
ZX120
NOMESCO Finland
Intravenous
2.2
6.8
68
294
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
3.5
6.8
30
80
R2110
NOMESCO Finland
Giving the first information
3.2
6.8
34
100
XF622
NOMESCO Finland
Measurement of minute volume of heart
6.3
6.8
17
25
A11CC03
ATC
alfacalcidol; systemic
3.6
6.7
29
76
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.7
415
3166
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.8
6.6
21
41
TJF80
NOMESCO Finland
Ostomy education
4.8
6.6
21
41
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
6.6
35
107
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
7.3
6.6
15
19
H02AB09
ATC
hydrocortisone; systemic
2.5
6.6
52
201
ZXA00
NOMESCO Finland
Right side
2.0
6.6
89
437
UKC02
NOMESCO Finland
Cystoscopy
3.4
6.6
30
82
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
6.6
30
82
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
4.0
6.5
25
59
XG413
NOMESCO Finland
Spirometry with oscillometry
3.0
6.5
37
117
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
6.4
6.5
16
23
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
6.9
6.4
15
20
C08CA05
ATC
nifedipine; systemic
15.3
6.4
10
6
RD160
NOMESCO Finland
NA
7.6
6.4
14
17
NFL22
NOMESCO Finland
Myotomy or tenotomy of hip or thigh
20.7
6.4
9
*
199
Kela drug reimbursment
Rufinamide
20.7
6.4
9
*
Q38.1
ICD-10 Finland
Ankyloglossia
3.2
6.3
32
95
EJC20
NOMESCO Finland
Operation on frenulum in mouth
3.7
6.3
26
66
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.6
6.3
27
71
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
6.2
182
1149
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
64.2
6.2
7
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
7.2
6.2
14
18
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
7.2
6.2
14
18
F84.8
ICD-10 Finland
Other pervasive developmental disorders
5.9
6.1
16
25
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.3
6.1
21
45
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
6.0
35
114
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
4.2
6.0
21
46
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
401
2316
2.40
26.34
24.0
15.3
1.2
1.2
mmol/l
0.38
390
2225
407
2382
2.38
25.68
21.1
14.3
1.2
1.2
mmol/l
0.60
388
2238
132
519
2.62
19.39
17.0
17.4
1.4
1.4
mmol/l
0.11
120
466
232
1177
2.19
19.15
15.5
12.1
1.4
1.4
mmol/l
0.11
223
1127
31
45
6.48
18.01
1.1
1.0
—
—
—
0
0
239
1273
2.08
17.02
10.8
11.0
5.4
5.2
kpa
0.47
230
1248
244
1323
2.05
16.45
10.9
11.2
5.8
5.7
kpa
0.35
235
1296
242
1319
2.03
15.99
11.0
11.2
1.0
1.1
mmol/l
0.08
195
1026
156
725
2.23
15.56
17.7
14.8
0.8
0.8
mmol/l
0.77
151
697
229
1241
2.01
15.24
10.9
10.4
23.7
23.6
mmol/l
0.35
223
1211
566
4221
2.33
14.70
24.1
14.3
139.4
139.3
mmol/l
0.41
560
4104
564
4218
2.29
14.22
23.9
14.3
4.0
4.0
mmol/l
3.77
554
4075
372
2453
1.83
12.99
7.7
5.8
154.9
138.4
u/l
2.19
355
2320
189
1023
1.93
12.18
3.2
3.1
2.4
2.4
mmol/l
0.25
177
932
241
1421
1.83
11.85
11.5
9.9
37.7
37.9
g/l
0.20
232
1355
220
1264
1.85
11.73
19.4
9.5
23.9
24.0
mmol/l
0.19
220
1259
231
1356
1.82
11.44
19.8
10.2
0.9
0.8
mmol/l
0.29
179
980
231
1358
1.82
11.38
19.8
10.3
5.1
5.0
kpa
0.88
226
1317
563
4323
2.08
11.29
12.3
9.5
28.5
26.4
u/l
0.72
554
4184
253
1542
1.78
10.96
11.7
9.5
27.8
27.8
umol/l
0.00
232
1416
287
1818
1.75
10.84
5.4
3.8
72.2
68.5
nmol/l
1.56
282
1730
218
1276
1.81
10.79
20.0
9.9
9.5
9.8
kpa
1.11
212
1238
62
235
2.53
9.61
10.3
7.0
196.9
231.7
ng/l
0.22
56
214
365
2540
1.65
9.20
13.5
9.0
5.7
6.1
mmol/l
3.03
351
2380
65
262
2.38
8.84
26.6
17.6
-0.7
-0.2
mmol/l
0.47
50
217
91
423
2.09
8.79
2.7
2.4
5.2
5.3
u/l
0.05
58
256
262
1690
1.66
8.77
7.2
4.9
—
—
—
0
0
82
372
2.13
8.42
2.8
2.4
6.5
5.9
iu/l
0.18
51
233
179
1070
1.70
7.85
4.3
3.7
—
—
—
0
0
122
655
1.84
7.73
4.8
3.3
2.5
2.6
g/l
0.72
117
630
47
175
2.54
7.58
3.7
4.2
—
—
—
0
0
237
1536
1.61
7.53
7.2
4.4
0.2
0.2
e6/l
0.10
185
1146
47
176
2.52
7.49
3.3
3.9
561.4
549.5
e6/l
0.05
38
126
115
615
1.83
7.36
9.2
8.9
6.4
6.6
umol/l
0.07
96
509
47
178
2.49
7.32
3.3
3.9
0.2
0.2
e9/l
0.06
38
128
45
168
2.53
7.22
3.5
4.1
22.9
26.2
%
0.95
45
168
165
991
1.67
7.02
5.4
3.8
0.7
0.8
e6/l
0.09
102
567
45
172
2.46
6.89
2.3
2.2
—
—
—
0
0
167
1013
1.65
6.82
5.3
3.9
2.7
1.9
e6/l
0.35
106
595
44
168
2.47
6.75
3.3
4.3
63.8
63.0
g/l
0.19
44
161
47
195
2.27
6.02
34.9
19.6
94.7
95.9
%
0.47
47
195
125
725
1.69
5.99
5.8
5.8
3.3
1.8
mg/l
1.02
102
508
13
25
4.78
5.66
2.9
2.6
21.5
18.1
umol/l
0.28
13
25
46
198
2.18
5.42
35.5
19.3
0.7
0.7
%
0.07
46
198
41
169
2.27
5.35
2.1
2.1
—
—
—
0
0
49
218
2.11
5.32
2.4
2.4
—
—
—
0
0
20
58
3.18
5.10
2.0
1.7
19.4
18.6
nmol/l
—
9
20
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
127
2.42
5.03
29.9
25.9
0.3
0.3
u/ml
0.09
22
87
579
4789
1.67
5.02
25.1
16.6
13.4
13.1
%
5.57
571
4723
85
472
1.72
4.76
1.5
1.3
21.1
18.8
nmol/l
0.69
79
411
33
131
2.34
4.71
5.5
5.9
2.6
2.1
ug/l
0.53
33
131
45
204
2.07
4.68
12.2
12.3
311.6
534.2
iu/ml
—
8
31
48
223
2.02
4.67
2.6
2.6
—
—
—
0
0
432
3391
1.43
4.53
4.1
3.4
14.5
14.5
pmol/l
0.17
405
3109
69
366
1.79
4.52
2.9
2.2
7.7
10.5
nmol/l
1.71
56
283
18
54
3.07
4.37
7.9
8.7
—
—
—
0
0
227
1610
1.42
4.17
5.2
4.7
—
—
—
0
0
37
164
2.10
4.10
2.4
2.0
—
—
—
0
0
475
3823
1.42
4.09
4.3
3.7
2.2
2.0
mu/l
1.49
455
3608
25
94
2.46
4.03
13.3
10.1
9.8
9.4
mg/l
0.14
25
86
169
1142
1.45
4.03
4.9
5.2
7.2
8.5
mmol/l
1.97
162
1077
100
1301
0.64
4.02
2.6
2.6
—
—
—
0
0
85
496
1.63
3.96
2.5
2.1
—
—
—
0
0
84
493
1.62
3.82
2.6
2.3
—
—
—
0
0
12
30
3.67
3.81
14.2
14.3
637.8
687.7
nmol/l
0.14
12
30
90
540
1.59
3.74
6.3
3.7
937.4
1437.4
ng/l
0.91
67
305
414
3281
1.37
3.72
14.4
12.1
3.6
3.4
e9/l
1.05
366
2694
39
186
1.95
3.58
15.6
14.2
412.4
1078.3
u/ml
—
5
26
47
239
1.84
3.56
1.8
1.4
—
—
—
0
0
47
239
1.84
3.56
1.8
1.4
—
—
—
0
0
31
136
2.11
3.55
4.0
5.0
22.1
24.8
umol/l
1.33
31
136
644
5577
2.01
3.52
27.8
17.2
131.9
133.5
g/l
1.84
639
5507
32
143
2.08
3.50
2.8
1.6
—
—
—
0
0
54
289
1.75
3.47
1.5
1.4
539.3
25379271.2
pmol/l
0.50
48
264
125
819
1.47
3.46
2.5
3.5
56.5
56.5
u/l
0.00
117
765
20
74
2.49
3.36
8.3
8.3
2.2
2.2
mg/l
0.02
14
65
23
91
2.33
3.36
5.1
5.5
—
—
—
0
0
56
306
1.72
3.35
1.7
1.9
2.4
2.4
mmol/l
0.23
46
246
126
835
1.45
3.29
1.8
1.6
96.9
98.8
pmol/l
0.19
67
429
18
64
2.59
3.28
6.0
7.3
—
—
—
0
0
18
64
2.59
3.28
6.7
7.5
—
—
—
0
0
97
1221
0.67
3.26
2.3
2.4
—
—
—
0
0
570
4819
1.45
3.07
18.7
11.5
23.1
24.2
mg/l
0.37
435
3236
539
5178
0.71
3.02
3.8
3.9
—
—
—
0
0
31
146
1.97
2.98
3.1
4.1
95.0
93.3
ml/min/173m2
—
6
41
96
616
1.48
2.95
2.7
2.2
—
—
—
0
0
24
104
2.13
2.87
2.7
1.9
1.1
1.1
g/l
0.15
18
89
109
727
1.43
2.74
1.9
2.0
1.2
1.2
mmol/l
0.18
103
666
333
2631
1.29
2.67
6.3
3.8
318.8
177.2
e6/l
—
10
31
16
60
2.45
2.65
4.1
5.3
24.1
25.9
ug/l
0.18
16
60
232
2469
0.77
2.58
2.0
2.0
—
—
—
0
0
27
128
1.95
2.58
1.6
1.4
—
—
—
0
0
20
356
0.49
2.57
1.4
1.5
—
—
—
0
0
18
73
2.26
2.54
9.8
9.9
—
—
—
0
0
35
182
1.78
2.53
2.5
2.3
—
—
—
0
0
32
163
1.81
2.48
2.3
2.0
—
—
—
0
0
278
2167
1.27
2.41
5.9
5.0
31.0
27.6
u/l
0.98
271
2087
37
200
1.71
2.36
2.7
5.2
228.9
1090.2
e6/l
0.71
30
141
37
200
1.71
2.36
2.7
5.2
33.4
8.9
e6/l
0.35
30
137
14
273
0.45
2.34
1.1
1.2
—
—
—
0
0
27
133
1.87
2.33
1.8
1.7
—
—
—
0
0
6
157
0.34
2.31
1.3
1.5
—
—
—
0
0
29
147
1.82
2.29
1.3
1.4
345.5
390.5
ug/g
0.59
21
68
171
1260
1.31
2.28
3.1
3.5
2.8
2.6
mg/l
0.79
156
1139
26
128
1.87
2.25
6.0
5.2
45.6
25.6
u/ml
0.27
26
123
29
150
1.78
2.16
10.5
26.7
72.2
72.0
%
0.03
29
150
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
73
2.14
2.12
1.1
1.2
—
—
—
0
0
16
67
2.19
2.12
2.6
2.4
1.9
1.7
ug/l
—
9
34
16
68
2.16
2.05
1.1
1.3
—
—
—
0
0
317
2543
1.24
2.05
2.8
2.1
5.3
5.4
mmol/l
0.46
300
2311
386
3166
1.24
2.03
11.7
10.1
35.9
36.6
%
0.55
372
3056
282
2236
1.24
2.02
4.2
3.2
34.5
36.5
mmol/mol
3.15
266
2124
10
34
2.69
2.01
1.9
1.1
—
—
—
0
0
36
203
1.64
2.00
9.6
11.4
23.2
22.9
mmol/l
0.19
36
191
9
29
2.83
1.98
1.0
1.4
—
—
—
0
0
21
101
1.91
1.97
1.9
1.8
—
—
—
0
0
40
234
1.58
1.93
2.1
1.8
—
—
—
0
0
32
177
1.67
1.92
3.3
2.9
—
—
—
0
0
6
15
3.64
1.85
1.7
1.8
—
—
—
0
0
6
15
3.64
1.85
1.7
1.8
—
—
—
0
0
6
15
3.64
1.85
1.7
1.8
—
—
—
0
0
6
15
3.64
1.85
1.7
1.8
—
—
—
0
0
9
31
2.65
1.83
1.6
1.7
—
—
—
0
0
9
31
2.65
1.83
1.6
1.7
—
—
—
0
0
9
31
2.65
1.83
1.6
1.7
—
—
—
0
0
245
1930
1.23
1.83
4.5
3.6
0.0
0.0
estimate
0.00
34
303
34
194
1.62
1.82
2.2
1.3
—
—
—
0
0
244
1928
1.23
1.76
6.9
5.3
0.0
0.0
estimate
0.00
40
334
24
126
1.75
1.74
2.5
2.3
2.6
1.9
mmol/l
0.56
16
100
14
243
0.51
1.73
1.7
1.8
—
—
—
0
0
64
774
0.72
1.70
2.3
2.2
—
—
—
0
0
28
156
1.65
1.66
5.1
7.4
143.9
414.0
g/mol
0.41
22
146
13
56
2.12
1.64
1.5
2.3
—
—
—
0
0
9
173
0.46
1.64
1.6
1.7
—
—
—
0
0
7
23
2.77
1.60
1.7
2.2
—
—
—
0
0
44
276
1.47
1.59
1.0
1.0
3.5
3.3
kpa
0.31
37
231
243
1939
1.21
1.56
4.6
3.6
0.0
0.0
estimate
0.00
38
325
44
280
1.45
1.49
1.0
1.0
-1.3
-2.2
mmol/l
—
7
61
44
280
1.45
1.49
1.0
1.0
6.9
7.3
kpa
0.69
37
234
55
666
0.72
1.49
1.7
2.0
—
—
—
0
0
19
286
0.59
1.47
1.9
1.8
—
—
—
0
0
7
25
2.55
1.46
1.6
2.6
—
—
—
0
0
9
35
2.34
1.44
2.7
1.9
—
—
—
0
0
279
2270
1.19
1.42
9.1
6.3
114.2
113.0
ml/min/173m2
0.36
182
1455
55
369
1.38
1.41
1.0
1.0
8.3
8.8
mu/l
0.25
48
322
15
73
1.88
1.40
1.1
1.3
—
—
—
0
0
15
75
1.83
1.31
1.8
1.6
—
—
—
0
0
30
182
1.51
1.30
3.5
3.0
—
—
—
0
0
6
23
2.37
1.21
1.8
2.5
—
—
—
0
0
6
23
2.37
1.21
2.8
7.1
—
—
—
0
0
8
34
2.14
1.19
3.8
6.0
216.9
209.4
ug/l
—
8
34
30
385
0.69
1.17
1.4
1.4
—
—
—
0
0
0
30
0.00
1.17
0.0
1.3
—
4.4
—
0
5
0
30
0.00
1.17
0.0
1.1
—
—
—
0
0
15
224
0.60
1.17
1.3
1.3
—
—
—
0
0
8
35
2.08
1.16
1.6
1.1
474.9
454.4
mu/l
—
8
35
0
33
0.00
1.15
0.0
1.2
—
—
—
0
0
8
36
2.02
1.12
1.6
1.1
67.9
75.3
%
—
8
36
12
59
1.86
1.11
1.2
2.8
3.5
3.0
nmol/l
0.10
12
52
73
532
1.27
1.09
2.5
2.2
53.5
53.7
ng/l
0.00
40
191
14
73
1.75
1.09
1.6
1.3
—
—
—
0
0
276
2289
1.15
1.04
4.4
3.4
52.1
56.1
ug/l
0.25
267
2174
48
558
0.76
1.03
1.3
1.2
3.4
2.9
u/ml
0.09
34
383
31
201
1.41
1.01
1.3
1.2
—
—
—
0
0
7
32
1.99
0.98
4.9
3.7
—
—
—
0
0
12
179
0.60
0.96
1.4
1.5
—
—
—
0
0
12
179
0.60
0.96
1.5
1.6
—
—
—
0
0
44
511
0.76
0.95
1.1
1.2
4.7
4.4
u/ml
0.04
14
182
6
24
2.27
0.94
2.0
1.9
—
—
—
0
0
88
672
1.21
0.90
1.6
1.5
170.1
373.9
u/ml
1.40
83
637
36
425
0.75
0.88
1.4
1.4
—
—
—
0
0
12
65
1.68
0.85
1.0
1.0
—
—
—
0
0
8
42
1.73
0.82
1.8
1.3
—
—
—
0
0
11
61
1.64
0.73
1.5
1.3
—
—
—
0
0
30
207
1.33
0.72
1.6
1.5
1295.0
1012.0
nmol/l
0.99
24
164
33
231
1.31
0.72
3.7
2.0
—
—
—
0
0
7
36
1.77
0.71
2.4
2.7
1556.6
1268.7
u/ml
—
7
36
71
752
0.84
0.71
1.1
1.1
—
—
—
0
0
12
70
1.56
0.67
1.0
1.0
—
—
—
0
0
10
56
1.62
0.65
2.3
1.4
0.5
0.8
ug/l
—
10
50
27
314
0.77
0.63
1.1
1.1
10.3
8.2
u/ml
0.15
15
191
11
149
0.66
0.63
1.5
1.4
—
—
—
0
0
11
149
0.66
0.63
1.5
1.4
—
—
—
0
0
11
149
0.66
0.63
1.5
1.4
—
—
—
0
0
11
149
0.66
0.63
1.5
1.4
—
—
—
0
0
11
64
1.56
0.62
1.0
1.0
—
—
—
0
0
5
27
1.68
0.61
1.2
1.1
1297.6
230.1
u/l
—
5
22
5
27
1.68
0.61
1.0
1.0
—
—
—
0
0
6
31
1.76
0.58
1.5
1.5
—
—
—
0
0
6
31
1.76
0.58
1.5
1.5
—
—
—
0
0
6
31
1.76
0.58
1.5
1.5
—
—
—
0
0
10
58
1.57
0.58
1.0
1.1
—
—
—
0
0
6
33
1.65
0.56
1.5
1.5
—
—
—
0
0
6
34
1.60
0.55
1.5
1.5
—
—
—
0
0
6
34
1.60
0.55
1.5
1.5
—
—
—
0
0
18
121
1.36
0.53
1.2
1.6
—
—
—
0
0
577
5122
1.13
0.52
26.6
16.0
38.5
39.4
%
3.05
529
4676
13
83
1.43
0.51
4.2
4.2
—
—
—
0
0
13
83
1.43
0.51
4.2
4.2
—
—
—
0
0
14
91
1.40
0.50
1.2
1.3
—
38.9
—
0
8
281
2427
1.08
0.44
3.8
2.7
1.2
1.1
mmol/l
1.23
273
2310
109
901
1.11
0.44
4.6
3.8
0.0
0.0
estimate
0.00
39
314
5
29
1.56
0.42
3.4
1.7
—
—
—
0
0
8
53
1.37
0.41
1.0
1.1
—
—
—
0
0
235
2233
0.93
0.41
1.6
1.9
1.5
4.3
u/ml
2.12
36
367
299
2599
1.07
0.39
4.0
2.9
4.2
4.3
mmol/l
1.70
293
2478
5
32
1.42
0.39
1.0
1.1
—
—
—
0
0
18
204
0.79
0.38
1.4
2.6
1.5
0.4
nmol/l
1.26
18
177
37
388
0.85
0.37
1.4
1.3
—
—
—
0
0
5
33
1.37
0.37
1.0
1.1
—
—
—
0
0
5
33
1.37
0.37
1.0
1.1
—
—
—
0
0
9
62
1.32
0.37
1.2
1.2
—
—
—
0
0
9
62
1.32
0.37
1.2
1.2
—
—
—
0
0
9
63
1.30
0.37
1.2
1.2
—
—
—
0
0
9
63
1.30
0.37
1.2
1.2
—
—
—
0
0
9
63
1.30
0.37
1.2
1.2
—
—
—
0
0
10
121
0.74
0.34
1.3
2.1
—
—
—
0
0
15
169
0.80
0.32
1.0
1.1
1.1
8.6
u/ml
—
5
52
26
200
1.18
0.30
1.2
1.1
5.4
7.1
iu/ml
—
6
29
15
167
0.81
0.29
1.1
1.1
—
—
—
0
0
42
426
0.88
0.29
1.5
1.2
—
—
—
0
0
20
151
1.20
0.28
1.4
1.1
—
—
—
0
0
9
109
0.74
0.27
9.8
4.5
41.1
49.0
%
—
9
109
10
69
1.32
0.27
1.2
1.1
—
—
—
0
0
42
423
0.89
0.26
1.3
1.2
—
—
—
0
0
26
271
0.86
0.26
1.1
1.1
3.1
0.4
u/ml
—
8
140
28
290
0.87
0.26
1.1
1.1
7.7
10.8
u/ml
0.35
16
186
12
86
1.27
0.26
12.3
8.8
5.2
4.8
kpa
1.29
12
86
15
111
1.23
0.25
1.2
1.3
4.3
6.6
u/ml
0.52
15
100
11
79
1.26
0.23
1.3
1.3
—
—
—
0
0
5
34
1.33
0.23
1.0
1.1
—
—
—
0
0
5
34
1.33
0.23
1.0
1.1
—
—
—
0
0
66
643
0.92
0.23
1.2
1.2
—
3.0
—
0
5
5
35
1.29
0.23
1.0
1.1
—
—
—
0
0
5
35
1.29
0.23
1.0
1.1
—
—
—
0
0
13
96
1.23
0.23
3.8
3.7
16.8
18.0
%
—
7
68
24
248
0.87
0.23
1.3
1.1
—
—
—
0
0
14
105
1.21
0.22
3.3
2.4
—
—
—
0
0
64
538
1.08
0.22
1.7
1.5
1.4
1.4
%
0.00
57
487
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
13
97
1.22
0.21
1.0
1.0
1.5
1.4
g/l
0.47
13
91
20
157
1.16
0.20
1.4
1.1
—
—
—
0
0
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
6
44
1.24
0.20
1.3
1.6
—
—
—
0
0
10
111
0.81
0.20
1.2
1.3
2.3
14.6
u/ml
—
10
102
7
54
1.17
0.18
2.6
2.2
—
—
—
0
0
43
421
0.92
0.18
1.3
1.1
21.2
6.3
u/ml
0.32
13
115
49
412
1.08
0.17
1.4
1.3
71.8
141.5
iu/ml
0.90
13
122
8
64
1.13
0.16
2.4
1.3
—
—
—
0
0
6
71
0.76
0.15
1.3
1.1
—
—
—
0
0
12
92
1.18
0.15
1.7
2.7
—
—
—
0
0
9
73
1.12
0.15
1.1
1.1
—
—
—
0
0
11
84
1.19
0.14
1.0
1.1
—
—
—
0
0
18
183
0.89
0.14
1.2
1.3
—
—
—
0
0
22
220
0.90
0.14
1.6
1.3
—
—
—
0
0
8
87
0.83
0.14
1.6
1.5
—
—
—
0
0
23
229
0.91
0.13
2.1
1.5
1.0
1.1
g/l
1.24
23
222
45
383
1.07
0.12
2.6
2.7
22.8
30.3
u/l
1.51
40
307
23
227
0.91
0.12
2.1
1.5
0.2
0.2
g/l
1.02
23
221
98
915
0.96
0.10
3.7
3.3
1.0
1.0
kg/l
0.05
18
178
5
39
1.16
0.10
1.2
1.2
—
—
—
0
0
36
344
0.94
0.09
1.9
1.9
—
—
—
0
0
10
79
1.15
0.09
1.7
1.8
—
—
—
0
0
7
59
1.07
0.08
1.3
1.4
—
—
—
0
0
7
60
1.06
0.08
1.6
1.1
—
—
—
0
0
13
106
1.11
0.08
2.3
1.8
—
—
—
0
0
48
452
0.96
0.07
1.3
1.2
14.1
13.7
iu/ml
—
10
93
8
68
1.07
0.07
2.3
1.7
—
—
—
0
0
286
2561
1.02
0.07
4.0
2.7
2.5
2.6
mmol/l
1.10
277
2407
332
2978
1.02
0.06
6.0
4.5
7.6
7.2
mm/h
0.39
321
2769
47
412
1.03
0.05
3.7
2.5
4483.8
6379.8
u/l
0.26
13
132
11
91
1.10
0.04
1.2
1.5
—
—
—
0
0
44
410
0.97
0.04
3.0
2.1
181.9
160.7
u/ml
0.24
27
184
27
234
1.05
0.04
1.3
1.5
2.0
10.8
u/ml
1.33
20
168
45
397
1.03
0.03
4.3
4.5
20.9
50.4
mg/mmol
0.39
35
318
282
2539
1.01
0.02
3.9
2.7
1.3
1.4
mmol/l
2.00
273
2403
11
100
1.00
0.00
3.5
2.1
—
—
—
0
0
46
413
1.01
0.00
2.9
2.1
—
—
—
0
0
10
86
1.05
0.00
1.0
1.5
39.9
39.1
u/l
—
10
81
138
1244
1.00
0.00
4.2
3.3
—
—
—
0
0
12
105
1.03
0.00
1.3
1.3
—
—
—
0
0
12
105
1.03
0.00
1.3
1.3
72.1
73.6
%
0.04
12
105
34
304
1.01
0.00
2.3
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
17.7
—
0
7
9
85
0.96
0.00
1.1
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
9
89
0.91
0.00
3.6
2.1
—
—
—
0
0
7
63
1.01
0.00
2.6
2.1
—
—
—
0
0
5
47
0.96
0.00
1.2
1.4
12.8
8.3
umol/l
—
5
47
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
70
0.90
0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
23.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_DELAY_MILES_CHILDH – Delayed milestone in childhood
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).